Warfarin Resistance Revisited by Frantz, Stephen C. & Madigan, Constance Padula
University of Nebraska - Lincoln
DigitalCommons@University of Nebraska - Lincoln
Proceedings of the Eighteenth Vertebrate Pest
Conference (1998) Vertebrate Pest Conference Proceedings collection
1998
Warfarin Resistance Revisited
Stephen C. Frantz
New York State Department of Health
Constance Padula Madigan
New York State Department of Health
Follow this and additional works at: http://digitalcommons.unl.edu/vpc18
This Article is brought to you for free and open access by the Vertebrate Pest Conference Proceedings collection at DigitalCommons@University of
Nebraska - Lincoln. It has been accepted for inclusion in Proceedings of the Eighteenth Vertebrate Pest Conference (1998) by an authorized
administrator of DigitalCommons@University of Nebraska - Lincoln.
Frantz, Stephen C. and Madigan, Constance Padula, "Warfarin Resistance Revisited" (1998). Proceedings of the Eighteenth Vertebrate
Pest Conference (1998). 44.
http://digitalcommons.unl.edu/vpc18/44
WARFARIN RESISTANCE REVISITED
STEPHEN C. FRANTZ, Wadsworth Center, New York State Department of Health, Empire State Plaza, P. 0 . Box
509, Albany, New York 12201-0509.
CONSTANCE PADULA MADIGAN, Center for Environmental Health, New York State Department of Health, 2
University Place, Western Avenue, Albany, New York 12207.
ABSTRACT: Roughly 50 years ago, the Wisconsin Alumni Research Foundation developed warfarin, the first
anticoagulant rodenticide. This product was something close to that desired elusive "magic bullet" of pest management.
Warfarin effectively killed rats and mice, required multiple feedings, and had a good margin of safety for non-target
species. The widespread adoption of anticoagulants somewhat changed the conduct of rodent control with a shift in
interventions toward toxicants and away from education and physical measures. The discovery of warfarin resistance
in the United States in Rattus norvegicus in 1971, and later in Mus musculus and Rattus rattus, heralded in another shift
in rodent pest mitigation. This shift was the development of more toxic anticoagulant products capable of killing with
one or a few feedings and with concomitantly greater risks to non-target species. Development of the more toxic
products both anticoagulant and non-anticoagulant continues today, although there is an increasing trend favoring
comprehensive approaches (i.e., integrated pest management [IPM]) which: emphasize educating clients and reducing
causative conditions; diminishing the role of toxicants; and, when necessary, using products of the least practical
toxicity. In this paper, the concept of counteracting anticoagulant resistance is blended with the sometimes necessary
use of anticoagulant rodenticides as part of IPM. Nationwide data from the former New York State Department of
Health Rodent Control Evaluation Laboratory (in cooperation with the Centers for Disease Control's former Urban Rat
Control Program) are examined regarding warfarin resistance in Rattus norvegicus. In samples from two dozen project
cities, population resistance levels ranged from 1.6% to 76.2% using the standard World Health Organization (WHO)
testing criteria. However, most survivors (i.e., resistant rats) of the initial test succumbed upon one or more re-
exposure(s) to warfarin using the same WHO testing protocol. The results are surprising and have implications on
interpreting the phenomenon of anticoagulant rodenticide resistance and on the pragmatic designing of rodent
management programs.
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INTRODUCTION
A new class of rodenticides became available in the
1940s with the introduction of warfarin by the Wisconsin
Alumni Research Foundation, Madison, Wisconsin.
The advantage of warfarin (and closely related
hydroxycoumarin compounds) was that it was effective in
killing rats and mice with a relatively low dose when
consumed regularly over a period of several days.
Further, a large amount of warfarin bait consumed at one
time would not effectively kill; thus, this new rodenticide
had a built-in safety factor regarding non-target species
such as cats, dogs, and children. Proper baiting
procedures should prevent access to baits by non-target
species, and certainly should prevent the repeated
ingestion necessary for intoxication. In essence, warfarin
was a product that was close to that elusive "magic bullet"
of pest management. An unfortunate outcome of this
discovery was that rodent control became largely an issue
of chemical intervention with less emphasis placed on
public health education, housekeeping, storage practices,
sanitation, and exclusion (proofing and stoppage). Not
surprisingly, anticoagulants have been the most preferred
rodenticides since World War II.
The identification of warfarin resistance in the United
States (known in Europe since 1958) in Rattus norvegicus
in North Carolina in 1971, and later in Mus musculus and
Rattus rattus (Jackson et al. 1985), heralded in another
shift in rodent pest mitigation. This shift was the
industry's increased interest in the development of more
toxic anticoagulant products (e.g., brodifacoum,
bromadiolone) capable of killing with one or a few
feedings. Unfortunately, the more potent anticoagulants
also have greater risks to non-target species.
Development of the more toxic products, both
anticoagulant (e.g., difethialone) and non-anticoagulant
(e.g., bromethalin), continues today. While not
remarkable in thoroughness nor consistency, there is an
increasing trend in some sectors of the pest management
industry favoring comprehensive approaches (i.e.,
integrated pest management [IPM]) which: emphasize
educating clients and reducing causative conditions;
diminishing the role of toxicants; and, when necessary,
using chemical products of the least practical toxicity
(Frantz and Davis 1991). Of course, concomitant with
changes in the industry are necessary changes in the
public's perception of what to expect in an IPM program.
In this presentation, the authors reexamine the
definition of "anticoagulant resistance" in Norway rats
(Rattus norvegicus) and how rodent control programs
might counteract anticoagulant resistance. In fact,
warfarin products themselves may be more useful than
was thought during the heyday of "super rat"
preachments. Nationwide warfarin resistance data
are examined from the New York State Department of
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Health's former Rodent Control Evaluation Laboratory (a
technical adjunct to the Centers for Disease Control and
Prevention's former Urban Rat Control Program).
MATERIALS AND METHODS
Animals
All animals used in this study were warfarin-resistant
Norway rats (Rattus norvegicus) belonging to one of three
different source groups. An animal was "resistant" if it
had survived the standard warfarin resistance screening
test; that is, it survived six days on .005% warfarin bait,
nine days on placebo (post-test), and had consumed a total
warfarin dosage of at least 12 mg/kg (Brooks and
Bowerman 1973, 1974).
Two source groups were comprised of wild-trapped
rats from project cities that had been sampled during the
nationwide anticoagulant rodenticide resistance
surveillance program, a service conducted in conjunction
with the federally funded CDC Urban Rat Control
Program (Frantz and Padula 1980). One group, mixed
source, contained rats from 23 project cities of the United
States and Puerto Rico where resistance levels in the
sampled rat populations ranged from 1.6% to 25.0%.
The second group of wild rats came from only the
Chicago, Illinois project where resistance levels in two
different sampled populations were 59.7% and 76.2%.
The third group of rats were all F, offspring of
various combinations of wild-trapped Chicago rats, some
of which had been identified as resistant (through the
screening test) and others which were of unknown
susceptibility (untested) to warfarin. Of 106 of the F,
Chicago offspring, 76.4% proved to be warfarin resistant
upon initial warfarin screening. This offspring group
provided age-related data for comparison with the wild-
trapped groups which were of unknown age when they
arrived at the laboratory.
Test Procedures
All wild-trapped rats were singly caged in mesh-
floored cages within about 24 hours of their arrival at the
laboratory and held for a minimum of three weeks before
being screened for anticoagulant rodenticide resistance (as
described in Frantz and Padula 1980). All F! Chicago
offspring were weaned and singly caged at an age of
approximately four weeks; they were then held until about
150 days of age before being screened for resistance.
During the period before anticoagulant resistance
screening, all animals received a diet of laboratory food
pellets (Wayne Lab Blox, Allied Mills, Inc., Libertyville,
Illinois) which contained "added" vitamin K. The overall
vitamin K activity of Lab Blox is unknown, but its use
may add to the homogeneity of the test animals by
minimizing variations in vitamin K status, particularly of
wild-trapped animals. Both food and water were provided
ad libitum. At pre-selection, one week before initiation
of pre-test, animals received lab meal (Purina 5001 Lab
Chow, Ralston Purina Co., St. Louis, Missouri),
containing no added vitamin K. Later, this meal was used
as the pre-test diet and then as the base for the warfarin
bait in each test or retest.
Pre-selection and selection criteria were that animals
were in a healthy condition, not pregnant, without obvious
wounds or other pathologies, and weighed at least 150
grams (Frantz and Padula 1980). These criteria are
essentially the same as given in the standard WHO
procedure (1970) and in Jackson et al. (1975), and were
used before each screening test or re-test procedure.
The pre-test, test and post-test procedures were essentially
the same as described in Frantz and Padula (1980) and
are presented as an algorithm in Figure 1; resistance
criteria also remained unchanged from the authors'
previous work.
Figure 1. Basic laboratory procedure for anticoagulant
resistance screening and retesting of Norway rats.
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As resistant animals were identified by the standard
screening procedure, they were assigned to one of three
retest interval groups (RIG)—or recovery interval
groups—depending on the interval between the last day an
animal received warfarin bait in the screening test and the
first day it was to receive its second laboratory exposure
to warfarin in the first retest (retest!) procedure. The
three retest interval groups were defined as follows:
Retest
Interval
Group (RIG)
< 1 month
1-2 months
>6 months
Davs Since Last
Limits
15-27
28-59
180-730
Received Warfarin Bait
Range Used
15-27
28-50
196-633
Once an animal was in the time range of its assigned
RIG, it was again tested (i.e., re-tested) by the same
procedure as in the standard warfarin resistance screening
(see Figure 1). Note that procedural differences occur
just prior to Retest Selection due to the necessary timing
requirements of the RIGs. That is, in the < 1 month
group, the authors wanted to retest at 15 days whenever
possible; but there was not sufficient time for a nine day
post-test, seven days on Lab Chow before pre-test2, and
a two day pre-test2—a total of 18 days. Therefore, the
three steps were merged; in essence, the post-test,
remained nine days, and pre-test2 remained two days, but
the time between these steps was reduced to four days.
If, for some reason, an animal did not meet basic test
criteria (body weight, health, etc.) (see Frantz and Padula
1980) at that time, it was held for another week or up to
16 days. After 16 days, the animal was reassigned to a
RIG with a longer interval between screening and retest.
Rats assigned to the other two RIGs which did not meet
criteria were treated similarly.
Many animals surviving the retest, were placed back
on a Lab Blox diet, held 12 days, returned to Lab Chow
for nine days (seven days + two day pre-test), and then
retested repeatedly (e.g., retest2, retest3, retest4, etc.) until
they died (to be reported elsewhere). For all retests after
the first, the interval between warfarin exposures was
fixed at 30 days. Note that some animals surviving the
first retest (retest,) were removed from this study for use
in other tests requiring resistant rats.
RESULTS AND DISCUSSION
In the < 1 month category, 52 rats from mixed
sources (excluding Chicago) were retested with 59.6%
(31/52) mortality; 18.0% (11/61) mortality resulted when
this test was repeated with Chicago-trapped rats (see
Table 1). In the second category of 1 to 2 months (see
Table 1), 61.2% (30/49) of the mixed-source rats died,
whereas 14.7% (10/68) of the Chicago rats died.
Repeating this test (1 to 2 month RIG) with 17 of the F,
Chicago offspring resulted in a mortality of 5.9% (1/17).
In the third RIG category of >6 months (see Table 1),
47 mixed-source rats were retested with 83.0% (39/47)
mortality; only six Chicago-trapped rats were retested and
one died (16.7%).
While test results beyond retest, will be discussed
elsewhere, it is worth noting that few mixed-source rats
survived retest3. That is, most animals of mixed-source
origin (excluding Chicago) tested from each of the three
RIG categories succumbed upon their fourth exposure to
warfarin bait in no-choice tests. Chicago-trapped rats in
the < 1 month, 1 to 2 month, and >6 month groups
commonly survived retest8, retesti0, and retest3,
respectively. Thus, some Chicago rats survived 11 lethal
doses of warfarin rodenticide, the last 10 of which were
consumed at 30 day intervals.
From these data, it appears that mortality for most
rats is not significantly affected by the recovery time
interval (RIG) for at least the categories of < 1 month and
1 to 2 months. The high mortality among mixed-source
rats in the >6 month category may be age related. For
Chicago rats in this latter category, not enough data are
available for analysis. Source (geographic origin),
however, is clearly important. Upon first retest, Chicago
rats have a significantly greater probability of survival
than those animals from mixed sources.
Thus, the most significant finding of these data is that
"resistant" (as by standard WHO screening measures)
Norway rats from many geographic locations are likely to
die upon re-exposure to warfarin, the very product which
is used to identify or define their resistance. That is, in
a baiting program with warfarin it appears that it should
be possible to continue to effectively use warfarin bait if
a time period of at least two or more weeks without
warfarin exposure is allowed between baiting cycles. In
fact, the two-week hiatus would be a good time to
complete more sustaining, non-toxic interventions such as
public health education, housekeeping, storage practices,
sanitation, and exclusion (proofing and stoppage). Even
in the Chicago area, or other areas that might be
identified with similar anticoagulant resistance
characteristics, rats will not be "resistant" to such non-
toxic interventions that are a significant part of a properly
conducted IPM program.
While it should be somewhat easier for rats to
consume a normally lethal dose of warfarin in the field
situation because of the higher warfarin concentration
(.025% in most commercial baits vs .005% in no-choice
laboratory tests), bait acceptance might be negatively
affected by the higher warfarin concentration and by the
availability of other food materials (Jackson et al. 1975).
Thus, the need for interventions to limit food resources
(e.g., sanitation) is underscored. The uninterrupted use
of warfarin baits over long periods of time should be
discouraged because such practices would select for
resistance (behavioral or other).
A second issue of importance raised by these data is
how to define the "resistance" of rats being utilized in
efficacy tests of rodenticidal products designed to kill
warfarin resistant rats. If a product is tested against
"resistant" rats from many geographic areas, the efficacy
results become unclear when more than half of such rats
might have succumbed to warfarin as shown with the
mixed-source test group. Repeated baiting cycles using
warfarin (with 30-day intervals of no warfarin) might well
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Table 1. Results of resistanta wild Norway rats' (Rattus norvegicus)
second exposure (no-choice feeding test) to .005% warfarin bait.
Source of Rats
Mixed Wild-Trappedc
Chicago Wild-Trapped
Chicago Lab-Bredd
Time Interval
to Retest,
(monthsb)
<1
1-2
>6
<1
1-2
>6
1-2
Rats
Retested
(Number)
52
49
47
61
68
6
17
Mortality
at Retest,
(Percent)
59.6
61.2
83.0
18.0
14.7
16.7
5.9
aAs determined by the standard warfarin screening test (Brooks and
Bowerman 1973 and 1974)
bNumber of months since exposed to warfarin bait
'Excluding Chicago Wild-Trapped rats
dF t offspring of Chicago Wild-Trapped rats
effectively reduce most rat populations without the
adverse consequence of increased risk for non-target
species intoxication.
CONCLUSIONS
These data raise interesting questions regarding the
significance of the warfarin resistance "problem" and how
to effectively conduct efficacy tests for products designed
to counteract warfarin resistance. Although many details
remain to be clarified, these studies support the need to
emphasize a non-chemical strategy for rodent control
efforts. Environmental sanitation and rat proofing would
go far to eliminate food and harborage resources and thus
curb breeding activity—affecting all animals in the
population as demonstrated decades ago by Davis (1950),
Holloway (1947), Orgain and Schein (1953), and others.
Elimination of the food alternatives would also increase
bait acceptance whenever the chemical strategy is
necessary. Under environmentally improved conditions,
it should be possible to kill resistant animals in most
localities with the standard anticoagulants (including
warfarin) and adjusted baiting schedules, rather than
switching to rodenticide baits which have a higher risk to
humans, pets, livestock, and/or wildlife.
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